✦ LIBER ✦

OP23.01: A prospective study evaluating the performance of first trimester combined screening for trisomy 21 using repeated sampling of the maternal serum markers PAPP-A and free β-hCG

✍ Scribed by C. K. Ekelund; D. Wright; S. Ball; I. Kirkegaard; P. Noergaard; F. S. Joergensen; S. Soerensen; L. Friis-Hansen; N. Toerring; B. H. Bech; O. B. Petersen; A. Tabor

Book ID: 115562993
Publisher: John Wiley and Sons
Year: 2012
Tongue: English
Weight: 60 KB
Volume: 40
Category: Article
ISSN: 0960-7692
DOI: 10.1002/uog.11606

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Prospective study evaluating performance

Prospective study evaluating performance of first-trimester combined screening for trisomy 21 using repeat sampling of maternal serum markers PAPP-A and free β-hCG

✍ C. Ekelund; D. Wright; S. Ball; I. Kirkegaard; P. Nørgaard; S. Sørensen; L. Frii 📂 Article 📅 2012 🏛 John Wiley and Sons 🌐 English ⚖ 83 KB

First Trimester Maternal Serum Screening

First Trimester Maternal Serum Screening Using Biochemical Markers PAPP-A and Free β-hCG for Down Syndrome, Patau Syndrome and Edward Syndrome

✍ Shiefa, S.; Amargandhi, M.; Bhupendra, J.; Moulali, S.; Kristine, T. 📂 Article 📅 2012 🏛 Association of Clinical Biochemistry of India 🌐 English ⚖ 611 KB

Screening for trisomy 21 in twin pregnan

Screening for trisomy 21 in twin pregnancies in the first trimester using free β-hCG and PAPP-A, combined with fetal nuchal translucency thickness

✍ Kevin Spencer 📂 Article 📅 2000 🏛 John Wiley and Sons 🌐 English ⚖ 61 KB 👁 1 views

In the ®rst trimester of pregnancy the biochemical markers free b-hCG and pregnancy associated plasma protein-A (PAPP-A) are used for the prenatal screening of trisomy 21, either alone or in combination with nuchal translucency (NT) thickness. In this study, I have analysed the distribution of these

First-trimester screening for chromosoma

First-trimester screening for chromosomal abnormalities by integrated application of nuchal translucency, nasal bone, tricuspid regurgitation and ductus venosus flow combined with maternal serum free β-hCG and PAPP-A: a 5-year prospective study

✍ S. R. Ghaffari; A. R. Tahmasebpour; A. Jamal; S. Hantoushzadeh; L. Eslamian; V. 📂 Article 📅 2012 🏛 John Wiley and Sons 🌐 English ⚖ 90 KB

The influence of fetal sex in screening

The influence of fetal sex in screening for trisomy 21 by fetal nuchal translucency, maternal serum free β-hCG and PAPP-A at 10–14 weeks of gestation

✍ Kevin Spencer; Charas Y. T. Ong; Adolfo W. J. Liao; Demetres Papademetriou; Kypr 📂 Article 📅 2000 🏛 John Wiley and Sons 🌐 English ⚖ 54 KB 👁 3 views

In a study of 2923 normal pregnancies and 203 pregnancies affected by trisomy 21 we have shown a signi®cant difference in the median MoM of the markers: fetal nuchal translucency, maternal serum free b-hCG and PAPP-A in the presence of a female fetus compared with a male fetus. For maternal serum fr

First-trimester screening for Down syndr

First-trimester screening for Down syndrome using nuchal translucency measurement with free β-hCG and PAPP-A between 10 and 13 weeks of pregnancy—the combined test

✍ P. De Biasio; M. Siccardi; G. Volpe; L. Famularo; F. Santi; S. Canini 📂 Article 📅 1999 🏛 John Wiley and Sons 🌐 English ⚖ 153 KB 👁 3 views

In a population of 1467 women attending the 'G. Gaslini' Institute for antenatal care, we evaluated first-trimester risk screening for Down syndrome using the 'combined test' based on ultrasound measurement of nuchal translucency (NT), maternal serum pregnancy-associated plasma protein A (PAPP-A) an